Tianyun K. Qiao
Chang Le Xi Street #127
Xi'an, 710032, China
Xi'an, 710032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Value of serum CEA and CA19-9 dynamic changes and trajectory modeling in prognosis assessment for non-small cell lung cancer.
Journal: Frontiers in oncology
Published: February 11, 2026
Correction: Association between genetically proxied glucosamine and risk of cancer and non-neoplastic disease: a mendelian randomization study.
Journal: Frontiers in genetics
Published: July 07, 2025
Peripheral CD8+PD-1+ T cells as novel biomarker for neoadjuvant chemoimmunotherapy in humanized mice of non-small cell lung cancer.
Journal: Cancer letters
Published: February 14, 2024
Association between genetically proxied glucosamine and risk of cancer and non-neoplastic disease: A Mendelian randomization study.
Journal: Frontiers in genetics
Published: September 28, 2023
Neoadjuvant SBRT combined with immunotherapy in NSCLC: from mechanisms to therapy.
Journal: Frontiers in immunology
Published: April 27, 2023
Correction to: Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model.
Journal: Cancer immunology, immunotherapy : CII
Published: December 26, 2022
Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model.
Journal: Cancer immunology, immunotherapy : CII
Published: June 16, 2022
The Effect of Hypoxia-Induced Exosomes on Anti-Tumor Immunity and Its Implication for Immunotherapy.
The Effect of Hypoxia-Induced Exosomes on Anti-Tumor Immunity and Its Implication for Immunotherapy.
Journal: Frontiers in immunology
Published: April 08, 2022
Unraveling tumor microenvironment of small-cell lung cancer: Implications for immunotherapy.
Journal: Seminars in cancer biology
Published: April 06, 2022
Strategies for the Construction of Mouse Models With Humanized Immune System and Evaluation of Tumor Immune Checkpoint Inhibitor Therapy.
Journal: Frontiers in oncology
Published: February 27, 2021
TFAP2A potentiates lung adenocarcinoma metastasis by a novel miR-16 family/TFAP2A/PSG9/TGF-β signaling pathway.
Journal: Cell death & disease
Published: December 30, 2020
Inhibition of LDH-A by Oxamate Enhances the Efficacy of Anti-PD-1 Treatment in an NSCLC Humanized Mouse Model.
Journal: Frontiers in oncology
Published: November 23, 2020
Last Updated: 09/26/2026